Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in TBPH — Theravance Biopharma, Inc.

CIK 1166588 NEW YORK, NY
Back to TBPH Full portfolio

Position in TBPH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,356,421
-$1,143,399 QoQ
Shares Held
138,613
-35.7% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. TBPH ranks #93 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in TBPH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,356,421 138,613
2026-03-31 $3,499,820 215,639
2025-12-31 $6,067,989 324,318
2025-09-30 $5,454,560 373,600
2025-06-30 $4,273,816 387,472
2025-03-31 $2,644,815 296,172
2024-12-31 $2,875,837 305,615
2024-09-30 $2,462,168 305,480
2024-06-30 $1,371,207 161,699
2024-03-31 $300,118 33,458
2023-12-31 $287,822 25,607
2023-09-30 $119,042 13,794
2023-06-30 $168,518 16,282
2023-03-31 $208,363 19,204
2022-12-31 $489,203 43,601
2022-09-30 $161,803 15,957
2022-06-30 $984,369 108,650
2022-03-31 $1,187,677 124,234
2021-12-31 $847,811 76,725
2021-09-30 $79,846 10,790
2021-06-30 $30,099 2,073
2021-03-31 $143,441 7,028
2020-12-31 $173,239 9,749
2020-09-30 $162,694 11,004
2020-06-30 $64,040 3,051
2020-03-31 $368,165 15,931